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The current study identiﬁes the role of lipocalin 2, a
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intestinal homeostasis, and show that mice lacking lipocalin
2 harbor colitogenic microbiota and are susceptible to
intestinal inﬂammatory disease.*Authors share co-ﬁrst authorship.
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http://dx.doi.org/10.1016/j.jcmgh.2016.03.007BACKGROUND & AIMS: Lipocalin 2 (Lcn2) is a multifunctional
innate immune protein whose expression closely correlates
with the extent of intestinal inﬂammation. However, whether
Lcn2 plays a role in the pathogenesis of gut inﬂammation is
unknown. Herein, we investigated the extent to which Lcn2
regulates inﬂammation and gut bacterial dysbiosis in mouse
models of IBD.
METHODS: Lcn2 expression was monitored in murine colitis
models and upon microbiota ablation/restoration. Wild-type
(WT) and Lcn2 knockout (Lcn2KO) mice were analyzed for
gut bacterial load, composition by 16S ribosomal RNA gene
pyrosequencing, and their colitogenic potential by co-housing
with interleukin (Il)10KO mice. Acute (dextran sodium sul-
fate) and chronic (IL10R neutralization and T-cell adoptive
transfer) colitis were induced in WT and Lcn2KO mice with or
without antibiotics.
RESULTS: Lcn2 expression was dramatically induced on
inﬂammation and was dependent on the presence of a gut
microbiota and MyD88 signaling. Use of bone marrow–chimeric
mice showed that nonimmune cells are the major contributors
of circulating Lcn2. Lcn2KO mice showed increased levels of
entA-expressing gut bacteria burden, and, moreover, a broadly
distinct bacterial community relative to WT littermates. Lcn2KO
mice developed highly colitogenic T cells and showed exacer-
bated colitis on exposure to DSS or neutralization of IL10. Such
exacerbated colitis could be prevented by antibiotic treatment.
Moreover, exposure to the microbiota of Lcn2KO mice, via
cohousing, resulted in severe colitis in Il10KO mice.
CONCLUSIONS: Lcn2 is a bacterially induced, MyD88-
dependent protein that plays an important role in gut homeo-
stasis and a pivotal role on challenge. Hence, therapeutic
manipulation of Lcn2 levels may provide a strategy to helpmanage diseases driven by alteration of the gut microbiota.
(Cell Mol Gastroenterol Hepatol 2016;2:482–498; http://
dx.doi.org/10.1016/j.jcmgh.2016.03.007)
Keywords: Gut Microbiota; Innate Immunity; Germ-Free Mice;
MyD88; Colitis; NGAL; Siderocalin; Neutrophils; IBD.
nﬂammatory bowel disease (IBD) is the collectiveIterm for chronic idiopathic inﬂammatory diseases of
the intestine, which are highly prevalent in North America
and Europe.1 The clinical symptoms of IBD may appear
similar, however, its etiology and pathology may vary be-
tween IBD patients because genetics, diet, and environ-
mental factors substantially inﬂuence the disease. Among
environmental factors, gut microbiotal dysbiosis has been
associated strongly with human IBD,2 underscoring the
involvement of host–microbe interactions.3 Furthermore,
IBD is associated with increased levels of a number of acute
phase proteins (APPs) that drive or dampen the inﬂamma-
tory response.4 One such APP is lipocalin 2 (Lcn2, human
ortholog, neutrophil gelatinase-associated lipocalin
[NGAL]; also known as siderocalin, 24p3), a multifaceted
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increased markedly in inﬂammatory diseases in both mice
and human beings.5–7 Accordingly, we have shown that fecal
Lcn2 is a sensitive, broadly dynamic, noninvasive biomarker
of intestinal inﬂammation.8 However, several studies have
shown that Lcn2 is not a mere bystander, but actively
involved in several physiological and pathophysiological
functions in IBD, renal diseases,9–11 and cancer.12,13
Among its diverse functions, one well-established role of
Lcn2 is to inhibit bacterial proliferation by chelating bac-
terial siderophores such as enterobactin, thus limiting iron
acquisition.14 However, Lcn2 alone cannot bind to ferric
(Feþ3) iron; instead, it requires the aid of small chemical
molecules such as mammalian siderophore 2,5 dihyox-
ybenzoic acid or catechol to bind and transport iron in and
outside of the cell.15–17 A recent report showed that Lcn2
also can complex with Feþ3-bound epigallocatechin gallate,
a polyphenol from green tea.16 Aside from its role in iron
homeostasis, Lcn2 also is involved in establishing systemic
hypoferremia during inﬂammation,13,18 inducing epithelial
cell secretion of chemokine interleukin (IL)8,19,20 mediating
tolerance to cellular iron overload,21 and, furthermore,
serves as a survival factor for epithelial cells.22 Previously,
we and Flo et al23 have shown that Lcn2-knockout (Lcn2KO)
mice are highly susceptible to lipopolysaccharide (LPS)- and
bacterial-induced sepsis, respectively.18 More recently,
Allred et al24 showed that Lcn2 limits the deleterious health
effects induced by synthetic radionuclides by mediating
their physiological transport via secondary ligand-based
sequestration mechanisms. Altogether, these ﬁndings indi-
cate broad and distinct physiological functions of Lcn2.
Neutrophils, the ﬁrst responder cell type to most
inﬂammation-inducing injuries, constitutively express and
store Lcn2 within their speciﬁc granules. Lcn2 is indis-
pensible for neutrophil inﬁltration, adhesion, and func-
tion.25,26 Recently, we showed that Lcn2 preserves the
bactericidal activity of neutrophil-derived host immune
protein myeloperoxidase (MPO) by preventing its inactiva-
tion by bacterial siderophore enterobactin.27 Lcn2 also is
known to deactivate and modulate polarization of macro-
phages,28 which are one of the most abundant leukocytes in
the intestinal mucosa. In addition, Lcn2 facilitates mucosal
regeneration25,26 by promoting cell migration29 and by
forming heterodimers with matrix metalloproteinase-9, a
metalloproteinase involved in tissue repair.30 Although it is
known that Lcn2 levels increased by several log orders of
magnitude in various models of inﬂammation,11,23 including
murine colitis7,8,31 and human IBD,6,32,33 the role of Lcn2 in
such inﬂammatory states is not known.
We hypothesized that Lcn2, which regulates gut bacterial
growth, systemic inﬂammation, andmucosal repair,mayplay a
key role in the gut homeostasis and IBD pathogenesis. Herein,
we studied the basic mechanisms that regulate Lcn2 expres-
sion and, moreover, its role in intestinal pathobiology. We
report that Lcn2 expression is regulated by microbiota-
induced MyD88 signaling, which allows for rapid robust in-
duction of this protein upon a range of challenges. Such Lcn2
expression helps keep microbiota in check, and consequently
protects the intestine against colitis inmultiplemurinemodels.Materials and Methods
Reagents and Antibodies
Reagent grade dextran sulfate sodium salt (DSS)
(reagent grade; molecular weight, 36–50 kilodaltons; cata-
log number 160110) was purchased from MP Biomedicals
(Solon, OH). Duoset enzyme-linked immunosorbent assay
(ELISA) kits for mouse and human Lcn2 and keratinocyte-
derived chemokine were obtained from R&D Systems
(Minneapolis, MN). a-Hu-Lcn2 SYBR Green mix and the
qScript complementary DNA (cDNA) synthesis kit were
procured from Quanta BioSciences (Gaithersburg, MD).
Guaiacol (2-methoxyphenol) was obtained from Alfa Aesar
(Ward Hill, MA). MPO was procured from Sigma (St. Louis,
MO). Ly6G antibody was purchased from Abcam (Cam-
bridge, MA). Rat anti-mouse IL10 receptor (IgG1) mono-
clonal antibody (aIL10R) and isotype control antibody
(rat anti-mouse IgG1) were procured from BioXcell (West
Lebanon, NH). Anti-mouse cluster of differentiation 45
(CD45)–Alexa Fluor 594 and CD326 monoclonal antibodies
were procured from BioLegend (San Diego, CA). RegIIIg and
Ang4 antibodies were a kind gift from Dr Lora Hooper (UT
Southwestern Medical Center, Dallas, TX). All other ﬁne
chemicals used in the present study were reagent grade and
procured from Sigma.
Mice
Lcn2KO mice were originally generated by Dr Shizuo
Akira (Department of Host Defense, Research Institute for
Microbial Diseases, Osaka University, Japan.) on a C57BL/6
background and were obtained via Dr Kelly Smith (Uni-
versity of Washington, Seattle, WA). The offspring were
cross-bred to obtain 4 possible genetic variants in the litter.
Wild-type (WT) littermates of the respective gene (ie, Lcn2,
Il10, myeloid differentiation primary response gene 88
[Myd88], or Toll-like receptor 5 [Tlr5]) KOs were used as
controls throughout the study. All mice used in the present
study were bred and maintained in speciﬁc pathogen–free
conditions at Emory University and Georgia State University
(Atlanta, GA), and The Pennsylvania State University (State
College, PA). The institutional animal ethical committees at
Emory University, Georgia State University, and The Penn-
sylvania State University approved the animal experiments.
Intestinal Epithelial Cell Culture
HT-29 human intestinal epithelial cells were cultured on
24-well plates in Dulbecco’s modiﬁed Eagle medium
(DMEM) supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin and streptomycin.34 The epithelial cells
were cultured on collagen-coated ﬁlters and then the
polarized epithelial cells were stimulated with ﬂagellin
basolaterally in serum-free media. After 24 hours, baso-
lateral and apical supernatants were collected separately
and assayed for NGAL secretion via ELISA.
Immunoblotting
Neutrophils, obtained from 4 different individuals, were
lysed in 0.5 mL RIPA buffer (Cell Signaling Technology, Inc,
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agnostics, Indianapolis, IN). The level of antimicrobial pep-
tides RegIIIg and Ang4 was analyzed in supernatant obtained
from ileal explant culture as described by Singh et al.35 Sam-
ples (25 mg/well) were fractionated by 12% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis and transferred to
a polyvinylidene diﬂuoride membrane and blocked for 1 hour
in 5.0% nonfat milk at room temperature. The blots were
incubated overnight at 4C with a-Hu-Lcn2 or rabbit anti-
mouse RegIIIg or Ang4. After 3 washes, blots were incu-
bated with anti-rabbit horseradish peroxidase and developed
by a chemiluminescence reagent. b-actin was used as a
loading control. Protein was quantiﬁed by a Bio-Rad (Bio-Rad
Laboratories Inc, Hercules, CA) reagent.T-Cell Transfer Colitis
Spleens harvested from female WT and Lcn2KO mice
were crushed using frosted glass slides and washed with
ﬂuorescence-activated cell sorter (FACS) buffer (1
phosphate-buffered saline [PBS] with 2% FBS). After pel-
leting the cells, red blood cells (RBCs) were removed using
RBC lysis buffer (Sigma) according to the manufacturer’s
protocol. Subsequently, the cells were resuspended in 2 mL
FACS buffer, ﬁltered through a 70-mm nylon cell strainer,
and incubated with Phycoerythrin (PE)-conjugated rat anti-
mouse CD4 and BB515-conjugated rat anti-mouse CD25 (BD
Biosciences, San Diego, CA). CD4þCD25- cells were sorted to
more than 99.5% purity using a BD FACSAria III cell sorter.
These cells were transferred (0.5  106 cells/mouse) to
4-week-old female recombination-activating gene 1 (Rag1)
KO mice via tail vein injection and colitis was monitored
after 8 weeks of CD4þCD25- cell administration.DSS-Induced Colitis
Eight-week-old male WT and Lcn2KO mice (n ¼ 4–5)
were administered 1.8% DSS (MP Biomedicals, Solon, OH) in
drinking water over a period of 7 days.36 This DSS concen-
tration (1.8%) was ascertained after titrating it in WT mice.
In brief, a set of WTmice from our colony were administered
1.5% or 2% DSS orally in drinking water and subsequently
monitored for slow and steady induction of acute colitis over
a period of 7 days. Lower doses of DSS (1.5%) were used in
Myd88KO mice because these mice are highly susceptible to
colitis.37 Induction of colonic inﬂammation was conﬁrmed
via fecal occult blood, diarrhea, and loss of body weight. On
day 7, mice were euthanized by CO2 asphyxiation. Blood
samples were collected at the time of euthanasia in a BD
microtainer (Becton Dickinson, Franklin Lakes, NJ) via retro-
orbital plexus. Hemolysis-free serum samples were obtained
after centrifugation and stored at -80C until further use.
Gut epithelial barrier function was evaluated in DSS-
treated WT and Lcn2KO mice using ﬂuorescein isothiocya-
nate (FITC)-dextran (4 kilodaltons; Sigma). Mice were
gavaged orally with FITC-dextran (50 mg/100 g body
weight) as a permeability tracer. After 6 hours, serum was
collected and FITC-dextran was analyzed using ﬂuorescence
spectroscopy.IL10R Neutralization-Induced Chronic Colitis
Colitis was induced in Lcn2KO mice and their WT lit-
termates by administering IL10R (IgG1) monoclonal anti-
body (a-IL10R mAb) as described earlier.38,39 In brief,
5-week-old male WT and Lcn2KO mice were administered
weekly anti-mouse a-IL10R mAb (1.0 mg/mouse, intraper-
itoneally) for up to 4 weeks. Body weight was measured
every week before injection. One week after the last injec-
tion the mice were euthanized and analyzed for standard
colitic parameters. In some experiments, 4-week-old male
Lcn2KO mice were maintained on ampicillin (1.0 g/L) and
neomycin (0.5 g/L)40 in drinking water for 4 weeks and
received a-IL10R mAb weekly as described earlier. Control
mice were given isotype control (rat anti-mouse IgG1)
antibody.
Co-housing
Immediately after weaning (3 weeks old), male Lcn2KO
and their WT littermates were co-housed with male Il10KO
mice at a ratio of 2:3 (WT or Lcn2KO:Il10KO) in each cage,
for up to 8 weeks. Animals were monitored regularly for
body weight and signs of colonic inﬂammation including
sticky stool, occult blood, and rectal prolapse. The data
provided the total number of Il10KO mice, which developed
rectal prolapse within 8 weeks after co-housing with either
WT or Lcn2KO mice.
Bone Marrow Chimera Generation
Eight-week-old Lcn2KO and their WT littermates were
exposed to whole-body radiation (850 rads) using a Shep-
herd Cesium Irradiator (JL Shepherd and Associates, San
Fernando, CA), and allowed them to stabilize for 2 hours.
Femurs from 4-week-old female WT and Lcn2KO donor
mice were ﬂushed with DMEM supplemented with 10%
FBS. Subsequently, the bone marrow cells were suspended
in the RBC lysis buffer and incubated for 5 minutes to lyse
erythrocytes. After incubation, cells were immediately pel-
leted by centrifugation at 400  g for 5 minutes and
resuspended in DMEM media supplemented with FBS
(10%). Before injection, the cells were washed and sus-
pended in sterile Hank’s balanced salt solution. After a
stabilization period, bone marrow cells (107 cells/mouse) in
Hank’s balanced salt solution were administered to irradi-
ated mice via retro-orbital injection to generate
WT/Lcn2KO and Lcn2KO/WT bone marrow chimera. We
also generated WT/WT and Lcn2KO/Lcn2KO bone
marrow chimera to use as a control in the present study.
Subsequently, mice were switched immediately to drinking
water containing neomycin (2 mg/mL) for the initial 2
weeks and then allowed 6 more weeks for reconstitution.
This process generated approximately 95%–99% chime-
rism as described earlier.41,42
MPO Activity
Colonic tissues from WT and Lcn2KO mice on different
treatments were homogenized in 0.5% hexadecyl-
trimethylammonium bromide (Sigma) in potassium phos-
phate buffer (pH 6.0). Subsequently, the mixture was
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14,000  g for 10 minutes at 4C. Clear supernatants were
collected and MPO assay was performed using the guaiacol
method as described by Singh et al.27 Brieﬂy, the suitably
diluted supernatants in potassium phosphate buffer were
dispensed in 96-well plates (Corning, Corning, NY) in trip-
licate. The reaction was initiated by adding ﬁnal concen-
trations of 100mmol/L guaiacol and 6.7  10-3% H2O2. The
change in absorbance at 470 nm was measured over a
period of 10minutes at 30-second intervals. One unit of
MPO activity was deﬁned as the amount that increased
absorbance at 470 nm by an outside diameter of 1.0 per
minute at 25C, calculated from the initial rate of reaction
using guaiacol as the substrate.
Total Bacterial Load Quantiﬁcation
Total bacterial DNA was isolated from equal amounts of
feces (50 mg) using the QIAamp DNA Stool Mini Kit (Qiagen
Inc, Valencia, CA). After 1/10 dilution, DNA was subjected to
quantitative polymerase chain reaction (PCR) using the
Quanti Fast SYBR Green PCR kit (Bio-Rad) with universal
16S ribosomal RNA (rRNA) primers 8F: 5’-AGAGTTT-
GATCCTGGCTCAG-3’, and 338R: 5’-CTGCTGCCTCCCGTAG-
GAGT-3’ to measure total bacteria. Fecal bacterial load is
expressed as the fold change relative to their WT littermates
using a standard curve generated with Escherichia coli DNA.
The level of EntA-expressing gut bacteria was analyzed by
the following primers: EntA-F: GGGCTGGAACTGGCGGGTAG,
and EntA-R: CTGGCGAGGTCAGAGGCGAG.
Quantitative Reverse-Transcription PCR
Total RNA was isolated from colonic tissue using TRI
reagent (Sigma) per the manufacturer’s protocol. The cDNA
was synthesized from 1.0 mg of puriﬁed RNA using the
qScript cDNA Synthesis Kit (Quanta BioSciences). Real-time
PCR was performed using the Step One Plus Real-Time PCR
System (Applied Biosystems Foster City, CA) in a 25-mL
reaction mixture containing cDNA, SYBR Green Master Mix
(Quanta BioSciences), and mouse-speciﬁc oligonucleotides
(Lcn2-F: AAGGCAGCTTTACGATGTACAGC, Lcn2-R: CTTGCA-
CATTGTAGCTGTGTACC; 36B4-F: TCCAGGCTTTGGGCATCA,
36B4-R: CTTTATTCAGCTGCACATCACTCAGA) as mentioned
earlier.43 The primers were procured from The Huck In-
stitutes of the Life Sciences, Genomic Core Facility, and The
Pennsylvania State University. The relative fold-difference
between different groups was calculated using the
comparative Ct [2-delta delta Ct (2-DD Ct)] method. The 36B4
gene was used as an internal standard to calculate the
relative expression.
ELISA
Fecal samples were prepared as described previously.8
In brief, frozen or freshly collected feces were dissolved to
make a 100 mg/mL fecal suspension in PBS containing 0.1%
Tween 20 and vortexed for 30 minutes at room tempera-
ture. Samples then were centrifuged at 4C for 10,000  g
for 10 minutes to collect clear supernatants. Blood was
collected at the time of mice euthanasia in a BD microtainer(Becton Dickinson) via retro-orbital plexus. To measure
colonic tumor necrosis factor (TNF)a, colonic tissue was
homogenized in RIPA buffer and the clear supernatant was
used to measure TNFa. Hemolysis-free sera was obtained
after centrifugation and stored at -80C until further use.
Mouse Lcn2 and TNFa Duoset ELISA kit (R&D Systems)
were used to quantify serum and fecal Lcn2 and colonic
TNFa per the manufacturer’s protocol. Likewise, serum
amyloid A was quantiﬁed in serum using an ELISA kit.
Serum immunoreactivity to LPS and ﬂagellin was analyzed
as described earlier.44Histology and Immunohistochemistry
After euthanasia, Swiss rolls of colons were ﬁxed over-
night in 10% neutral buffered formalin solution and then
stored in 70% ethanol. Colons were processed for parafﬁn
embedding and serial sections (5 mm) were collected and
stained with H&E. Histologic scoring was performed as
described previously.45
For neutrophil staining, the parafﬁn-embedded colon
sections were stained with rat anti-mouse antibody speciﬁc
to neutrophil marker Ly6G (Abcam) and visualized under
ﬂuorescent microscopy. An appropriate negative isotype
control (rat IgG2b; Abcam) was included to omit nonspeciﬁc
staining.
Immunoﬂuorescence staining was performed in parafﬁn-
embedded colon sections from control and DSS-treated WT
mice using anti-mouse antibodies speciﬁc to Lcn2, CD45
(leukocyte marker), and CD326 (epithelial cell adhesion
molecule, a marker for epithelial cells). In brief, deparafﬁ-
nized and rehydrated colon sections initially were blocked
with normal horse serum (5% in PBS) and then incubated
with primary antibodies (Lcn2 [R&D Systems] and
CD45–Alexa Fluor 594 [BioLegend], or Lcn2 and
CD326–Alexa Fluor 594 [BioLegend]) for 18 hours in the
dark at 4C. After washing, sections were incubated with
secondary antibody against Lcn2 (rabbit anti-goat Alexa
Fluor 488; Molecular Probes, Inc, Eugene, OR) for 1 hour at
room temperature. Sections ﬁnally were washed with PBS
and mounted with Fluoroshield with 40,6-diamidino-2-
phenylindole (Sigma, St. Louis, MO). Images were acquired
using a Keyence BZ-9000 ﬂuorescence microscope (Keyence
Corporation of America, Itasca, IL).16S rRNA Gene Pyrosequencing
Sample collection and DNA isolation. Fecal pellets
from age- and sex-matched Lcn2KO (n ¼ 4) and WT (n ¼ 5)
littermates were collected under hygienic conditions and
stored in sterile vials at -20C before processing. DNA was
extracted from 0.5 g fecal material using the MO-BIO Pow-
erSoil DNA isolation kit (MO-BIO Laboratories, Carlsbad, CA)
according to the manufacturer’s instructions. The DNA
concentration was analyzed using the Qubit 2.0 Fluorometer
and related high-sensitivity double-stranded DNA kit, ac-
cording to the manufacturer’s instructions (Life Technolo-
gies, Grand Island, NY). DNA concentrations were
standardized to 10 ng/mL to be used in library preparation.
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25 uL Illumina tag PCRs (Illumina, San Diego, CA) to amplify
the V4 region of the 16S rRNA gene using primers 515F and
806R as detailed in Earth Microbiome Project (http://www.
earthmicrobiome.org/). Each reaction contained ﬁnal con-
centrations of 1  PCR buffer, 0.8 umol/L deoxynucleotides
(dnTPs), 4 umol/L 515F Illumina barcoded forward primers,
4 umol/L 806R reverse primers, 0.25 U Taq polymerase, and
10 ng of template DNA. PCR was performed using the PTC-
200 Thermocycler (MJ Research Incorporation, Waltham,
MA). Reactions were held at 94C for 3 minutes to allow for
the DNA to denature, followed by 35 cycles at 94C for 45
seconds, 50C for 60 seconds, and 72C for 90 seconds, with
a ﬁnal extension time of 10 minutes at 72C followed by
holding at 4C. PCR products were visualized on a 2%
agarose E-gel (Life Technologies, Carlsbad, CA).
Library preparation and sequencing. The DNA con-
centration of successful PCR products was analyzed using
the Qubit 2.0 Fluorometer, and equimolar amounts of each
PCR product were pooled and Solid-phase reversible
immobilization (SPRI)-bead puriﬁed using the Agencourt
AMPure XP-PCR Puriﬁcation Kit according to the manufac-
turer’s instructions (Beckman Coulter, Indianapolis, IN).
Cleaned, pooled libraries were quality checked using the
Agilent 2100 Bioanalyzer and the related Agilent High-
Sensitivity DNA Chip, according to the manufacturer’s in-
structions (Agilent Technologies, Santa Clara, CA).
University of Tennessee-Knoxville (Knoxville, TN) per-
formed the sequencing. Library pools were size-veriﬁed
using the Fragment Analyzer CE (Advanced Analytical
Technologies, Inc, Ames, IA) and quantiﬁed using the Qubit
high-sensitivity double-stranded DNA kit (Life Technologies,
Carlsbad, CA). After dilution to a ﬁnal concentration of 1
nmol/L containing 10% PhiX V3 library control (Illumina,
San Diego CA), the library pools were denatured for 5 mi-
nutes in an equal volume of 0.1 N NaOH, further diluted to
12 pmol/L in HT1 buffer (Illumina), and sequenced using
the IlluminaMiSeq V2 300 cycle kit cassette and set for 2 
150 base (paired-end reads).
Sequences analysis. Forward and reverse reads were
paired, trimmed at a length of 252 bp, and qualityﬁlteredwith
an expected error of less than 1% using USEARCH v7.46
Operational taxonomic units were picked using the open
reference USEARCH61 algorithm,46 and taxonomy assignment
was performed using the Greengenes 16S rRNA gene database
(13-8 release; 97%). Sequences that did not match the data-
base subsequently were clustered using de novo clustering.46
Beta diversity. Beta diversity was estimated by calcu-
lation of unweighted UniFrac distances between samples.
Principal coordinate analysis was performed on the UniFrac
distance matrices. The analysis of similarities (ANOSIM)
metric was used to determine the degree to which metadata
parameters explained patterns in the UniFrac distancematrix.Microarray Analysis
Microarray analyses were performed in biological trip-
licates using colonic tissue of 8-week-old male Lcn2KO mice
and their WT littermates at the Emory BiomarkerMicroarray Core. Brieﬂy, messenger RNA samples were
reverse-transcribed, ampliﬁed, labeled, and used to probe
mouseWG-6 v2 chips purchased from Affymetrix (Santa
Clara, CA). Samples were assayed using a Molecular Devices
Gene Pix (4100A) (Silicon Valley, CA), and raw ﬂuorescence
readings were processed by an algorithm designed to
reduce spurious readouts of gene activation. Microarray
data were quantile-normalized using freely available scripts
written in R (www.R-project.org). Signiﬁcantly altered
genes were identiﬁed using signiﬁcance of analysis of
microarray analyses and assessed by hierarchal clustering
and principle component analysis using Spotﬁre Decision
Site for Functional Genomics software (TIBCO, Somerville,
MA) to determine relatedness of gene expression patterns
resulting from loss of Lcn2.
Statistical Analysis
Data are presented as means ± SEM. Signiﬁcance of
difference between 2 groups was analyzed by an unpaired t
test. One-way analysis of variance followed by the Dunnett
(when the mean of each column was compared with the
mean of a control column) or the Tukey (when the mean of
each column was compared with the mean of every other
column) multiple comparison test was used to compare
more than 2 groups. All statistical analyses were performed
using GraphPad Prism 6.0 program (GraphPad Software, Inc,
La Jolla, CA).
Results
Inﬂammatory Conditions and Microbial Products
Up-Regulate Lcn2 Expression In Vivo and In Vitro
IBD is associated with increased levels of fecal and
serum Lcn2. Although many cell types have the capacity to
make Lcn2 in vitro, it is not clear, in vivo, which cell types
produce Lcn2 basally and upon colitis. Herein, we examined
the colonic expression of Lcn2 in DSS-induced colitic WT
mice and spontaneously colitic Il10KO and Tlr5KO mice in
comparison with noncolitic controls. As shown in Figure 1A,
the expression of Lcn2 is not conﬁned to the gut epithelia
but also includes other cell types in the colon. This obser-
vation was conﬁrmed further by examining the colocaliza-
tion of Lcn2 with leukocytes and/or epithelial cells in the
colonic tissue sections of DSS-treated mice using dual
immunoﬂuorescence staining (Supplementary Figure 1A).
To further dissect the relative contribution of immune and
nonimmune cells to the pool of systemic Lcn2, we generated
Lcn2 bone marrow chimeras and measured their Lcn2
expression. Our results showed that nonimmune cells are
the major contributor of circulating Lcn2 at the basal level
as well as in response to DSS and LPS challenge in vivo
(Supplementary Figure 2). In comparison, immune cells also
contribute to the pool of circulating Lcn2, but to a sub-
stantially lesser extent.
A previous study reported that the intestinal epithelial
cells could be one of the major producers of Lcn2 during
IBD.47 Consistent with that study, we also found that HT29
cells (human intestinal epithelial cell line) spontaneously
secrete Hu-Lcn2 (also known as NGAL), and its secretion
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double-stranded RNA [polyinosinic acid:cytidylic acid (poly
I:C)] and ﬂagellin (Figure 1B), which are TLR3 and TLR5
ligands, respectively. However, HT29 cells failed to induce
Hu-Lcn2 in response to either LPS or interferon-g
(Figure 1B). To assess the vectorial direction of Hu-Lcn2
secretion, we measured Hu-Lcn2 secretion in polarized
HT29 cells and found that most of the spontaneous Hu-Lcn2
secretion was conﬁned to the apical compartment with
negligible amounts in the basolateral side when unstimu-
lated (Figure 1C). Surprisingly, HT29 cells stimulated with
basolateral ﬂagellin increased their Hu-Lcn2 secretion in the
apical compartment by only 2-fold, whereas the basolateral
secretion of Hu-Lcn2 was increased by approximately 30-
fold (Figure 1C).
We also found that human neutrophils remain a rich
source of intracellular Hu-Lcn2 because they expressed
approximately 6-fold more Hu-Lcn2 than HT29 epithelial
cells. Interestingly, even though human neutrophils con-
tained both the monomeric and dimeric forms of Lcn2 in the
intracellular pool,48 neutrophils only secreted the dimeric
form of Lcn2 upon stimulation with a variety of stimuli
(Supplementary Figure 3). In comparison, nonimmune cells
such as intestinal epithelial cells (IECs) produce and secrete
only the monomeric form of Hu-Lcn2.48 Altogether, these
results suggest that differential secretion patterns of Hu-
Lcn2 by neutrophils and the IECs contribute to the intra-
cellular and extracellular/systemic pool of Hu-Lcn2 during
normal and inﬂamed states.
Gut Microbiota Regulates Lcn2 Expression in a
MyD88-Dependent Manner
Among its diverse functions, Lcn2 exerts bacteriostatic
effects by chelating bacterial siderophore and inhibiting
bacterial proliferation.14,23 To examine whether the gut
microbiota inﬂuences Lcn2 expression, we measured basal
Lcn2 levels in germ-free (GF) and conventional WT mice. GF
mice showed signiﬁcantly reduced serum and fecal Lcn2
(Figure 2A). Upon conventionalization of GF mice via oral
gavage of cecal contents from conventional WT mice, the
colonic and ileal messenger RNA transcripts of Lcn2 were
increased at day 4 and peaked at day 7 (Figure 2B). Simi-
larly, a time-dependent increase in fecal Lcn2 was observed,
which peaked at day 4 in conventionalized GF mice
(Figure 2C). These results suggest that the gut microbiota is
required to maintain normal levels of Lcn2 in the lumen andFigure 1. (See previous page). Increased colonic Lcn2 in var
Il10KO, Tlr5KO, Myd88KO, and Lcn2KO mice (n ¼ 4) were eut
were treated with DSS (1.8%) for 1 week. (A) Images show the im
of each image show the high-magniﬁcation image (400) of th
denote Lcn2 immunostained cells in colonic tissue sections. HT
Salmonella ﬂagellin (high-performance liquid chromatography p
double-stranded RNA polyinosinic acid:cytidylic acid (poly I:C) (1
U/mL) in serum-free media for 24 hours. To study the vectorial d
HT29 cells were grown on 5-cm2 ﬁlters. Flagellin (100 ng/mL) w
Lcn2 produced in the supernatant obtained from control and st
way analysis of variance with (B) the Dunnett test and (C) th
considered statistically signiﬁcant. ***P < .001. Con, control; Flcirculation, which may in turn regulate the microbiota,
speciﬁcally by chelating the iron-scavenging siderophores.
Next, we asked whether the innate and adaptive arms of
the immune system are involved in regulating Lcn2
expression during intestinal inﬂammation. Myd88KO mice,
which lack all TLR signaling except TLR3, showed low levels
of systemic and colonic Lcn2 in comparison with their WT
littermates (Figure 2D). Interestingly, Myd88KO mice failed
to up-regulate either fecal or serum Lcn2 to the extent of
WT mice in response to DSS treatment (Figure 2E and F),
even though these mice developed severe pathology (data
not shown) similar to that observed earlier.37,49 In contrast,
the colonic and systemic Lcn2 were unaltered in adaptive
immune response–deﬁcient Rag1KO mice (data not shown).
Altogether, these data suggest that Lcn2 is a bacterially
induced and in part MyD88-regulated protein. In addition,
the association between increased susceptibility to DSS-
induced colitis and the impaired Lcn2 response in
Myd88KO mice suggest that Lcn2 may have a protective role
against gut inﬂammation.
Lcn2-Deﬁcient Mice Display Altered Colonic
Gene Expression and Gut Bacterial Dysbiosis
To study the effects of Lcn2 deﬁciency on gut physiology,
we performed a microarray analysis to examine global
colonic gene expression in Lcn2KO mice relative to age- and
sex-matched WT littermates in biological triplicates. Loss of
Lcn2 resulted in signiﬁcant up-regulation of 46 genes and
down-regulation of 92 other genes in the colons of Lcn2KO
mice assayed (Supplementary Figure 4). These changes are
consistent with the notion that to compensate for Lcn2
deﬁciency, Lcn2KO mice have signiﬁcantly up-regulated
acute phase protein (a-1-antitrypsin [serpin peptidase in-
hibitor, clade A (a-1 antiproteinase, antitrypsin), member
1b]), major urinary proteins, which are members of the
lipocalin superfamily, and cation transporters (Slc25a36 and
Slco1b2) in the colon. Notably, Fetuin-A and vitronectin,
which favor bacterial adherence, were up-regulated signiﬁ-
cantly in the colons of Lcn2KO mice.50,51 Accordingly,
Lcn2KO mice showed 3-fold more bacteria in feces, most of
which express entA (2,3-dihydro-2,3-dihydroxybenzoate
dehydrogenase, an enzyme involved in enterobactin syn-
thesis) (Figure 3A). Lcn2KO mice harbor a large proportion
of gram-negative bacteria (eg, Enterobacteriaceae) in the
gut, as monitored by using Drigalski lactose agar medium
(Figure 3B). Concomitantly, increased fecal ﬂagellin, whichious murine models of colitis. Age-matched male BL6 WT,
hanized and Swiss rolls were made from the colon. WT mice
munostaining of Lcn2 (brown staining) in colons. Lower panel
e boxed area in the respective upper panels. Yellow arrows
29 cells were stimulated with the indicated stimuli with either
uriﬁed, 100 ng/mL) and Salmonella LPS (10 mg/mL), synthetic
0 mg/mL), and proinﬂammatory cytokine interferon (IFN)g (100
irection of Lcn2-secretion polarized epithelial cell monolayer,
as applied basolaterally. (B and C) Bar graphs represent Hu-
imulated IECs. Results are expressed as means ± SEM. One-
e Tukey multiple comparison test were used. P < .05 was
iC, ﬂagellin; pIC, polyinosinic acid:cytidylic acid.
Figure 2. Reduced systemic and fecal Lcn2 in GF and MyD88-deﬁcient mice. Lcn2 was measured in age- and sex-
matched GF and conventional mice (n ¼ 5-6) using ELISA. Messenger RNA transcript of ileal and colonic Lcn2 was exam-
ined using quantitative reverse-transcription polymerase chain reaction. (A) Serum and fecal Lcn2 levels in conventionalized
and GF mice. (B) mRNA transcript of Lcn2 in ileum and colon. (C) Time-dependent excretion of fecal Lcn2 in GF and con-
ventionalized GF mice. (D) Serum and fecal Lcn2 in Myd88KO mice and their WT littermates (n ¼ 5). Colitis was induced by
orally administering DSS (1.5%) to 8-week-old male WT and Myd88KO mice. (E) Line graph represents the time-dependent
increase in fecal Lcn2 after DSS stimulation. (F) Bar graph represents serum Lcn2 control and DSS-treated WT and
Myd88KO mice. Results are expressed as means ± SEM. (A, C, D, and E) Unpaired t test and (B and F) 1-way analysis of
variance with the Tukey multiple comparison test were used. P < .05 was considered statistically signiﬁcant. *P < .05, **P <
.01, and ***P < .001. post conv, post conventionalization with WT gut microbiota.
July 2016 Microbiota-Dependent Colitis in Lcn2KO Mice 489
Figure 3. Increased gut bacterial load and distinct bacterial community in Lcn2-deﬁcient mice. (A) Gut bacterial load
analyzed by real-time polymerase chain reaction using universal primer of bacterial 16S rRNA and entA gene. (B) Gram-
negative bacterial analysis by Drigalski lactose agar. (C) Principal coordinate analysis of unweighted UniFrac distances be-
tween fecal microbial communities from 12-week-old Lcn2KO and their WT littermates (n ¼ 4-5). Each point represents a
discrete sample. Samples clustered closely together have similar bacterial community structure but distant points have distinct
communities. (D and E) Relative abundance of major bacterial phyla in Lcn2KO mice and their WT littermates. (F) Immunoblot
of antimicrobial proteins Reg-IIIg and Ang4 in the ex vivo ileal explants from WT and Lcn2KO mice. Results are expressed as
means ± SEM. (A and E) An unpaired t test was used. P < .05 was considered statistically signiﬁcant. *P < .05 and ***P < .001.
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teria ﬂagella, was found in Lcn2KO mice (data not shown).
Our present ﬁndings are reminiscent of the gut microbiotal
dysbiosis of Tlr5KO mice, which are predisposed to the
development of moderate to robust spontaneous colitis.7
However, unlike Tlr5KO mice, Lcn2KO mice did not
develop spontaneous gut inﬂammation (data not shown).To further evaluate the dysbiotic microbiota in Lcn2KO
mice, we subjected the mice fecal samples to 16S rRNA
sequencing. Principal coordinate analysis of unweighted
UniFrac distances between fecal microbial communities
showed a distinct clustering by genotype, suggesting that
bacterial communities are signiﬁcantly different in Lcn2KO
and WT mice (Figure 3C). Moreover, the uses of only a few
July 2016 Microbiota-Dependent Colitis in Lcn2KO Mice 491operational taxonomic units were sufﬁcient to discriminate
microbiota from each experimental group (Supplementary
Figure 5). Bacteroidetes phylum, which is more prevalent
in IBD,52 was found increased in Lcn2KO mice (Figure 3D
and E). Notably, Tenericutes, a bacterial phylum that de-
creases upon DSS challenge,53 also was reduced in mice
lacking Lcn2 (Figure 3D and E). To a lesser extent, the
phylum Proteobacteria, which is regarded as opportunistic,
colitogenic, and, a marker of dysbiosis, was increased
modestly in Lcn2KO mice (Figure 3D and E). The gut
bacterial dysbiosis and increased bacterial burden in
Lcn2KO mice did not result in spontaneous gut inﬂamma-
tion but, rather, eventuated in increased expression of
Paneth cell–speciﬁc antimicrobial proteins Ang4 and
RegIII-g54 (Figure 3F), possibly to compensate for Lcn2
deﬁciency.Lcn2-Deﬁcient Mice Are Susceptible to
DSS-Induced Acute Colitis and Display
Colitogenic T Cells
Lcn2 prevents mucosal damage by promoting mucosal
regeneration in an experimental model of gastric dam-
age.29 However, mice lacking lipocalin-type prostaglandin
D synthase, a member of the lipocalin family of proteins,
are protected from DSS-induced colitis.55 However, it still
is unclear whether Lcn2 show procolitogenic or anti-
colitogenic properties during IBD. To study whether
deﬁciency of Lcn2 reduces or exacerbates murine colitis,
8-week-old Lcn2KO and their WT littermates were given
1.8% DSS in drinking water for 7 days. As shown in
Supplementary Figure 6A and B, Lcn2KO mice showed
greater body weight loss and colonic inﬂammation as
characterized by more occult blood, colon shortening, and
splenomegaly (Supplementary Figure 6C). In addition, the
level of systemic inﬂammatory marker serum amyloid A
and intestinal permeability, as measured by FITC-dextran,
were increased in DSS-treated Lcn2KO mice when
compared with WT littermates (data not shown). Inter-
estingly, the increased DSS-induced pathology in Lcn2KO
mice was not accompanied by increased levels of colonic
MPO, a marker of neutrophil inﬁltration (Supplementary
Figure 6D) despite the observed extensive colonic dam-
age (Supplementary Figure 6E and F). In accordance, we
performed immunoﬂuorescence staining for neutrophil-
speciﬁc marker Ly6G and reduced neutrophil inﬁltration
was observed in the colonic sections obtained from
Lcn2KO mice (Supplementary Figure 6G and H), which
explains the impaired MPO activity in Lcn2-deﬁcient mice.
Such compromised neutrophil recruitment also may ac-
count for severe colitis development in Lcn2KO mice
because neutrophils play a key role in mucosal healing by
producing the mediators required for inﬂammation reso-
lution and promoting the recruitment of other immune
cells.56
Next, we asked whether Lcn2 deﬁciency also could
impact the immune cell–mediated colitis. Accordingly, we
used the adoptive T-cell transfer model of colitis to inves-
tigate the colitogenic potential of Lcn2-deﬁcient T cells.Brieﬂy, we transferred FACS-sorted CD4þCD25- T cells from
WT and Lcn2KO mice to Rag1KO mice and monitored in-
duction of colitis. As shown in Figure 4, recipients of Lcn2KO
effector T cells (Lcn2KO-R) showed exacerbated and robust
colitis relative to mice receiving WT T cells. Such exacer-
bated colitis featured greater loss in body weight, colon
shortening, colonic inﬂammation (Figure 4A–C), and
increased inﬁltration of inﬂammatory cells as observed in
H&E-stained colons (Figure 4D and E). Collectively, these
ﬁndings suggest that Lcn2 deﬁciency not only may dysre-
gulate gut microbiota homeostasis, but also could induce
substantial intrinsic changes in immune cells (ie, neutro-
phils, T cells) that may contribute to the augmented colitis
phenotype observed in Lcn2KO mice.
Lcn2KO Mice Are Prone to Chronic Colitis
on IL10R Neutralization
The earlier-described results suggest that Lcn2KO mice
might be particularly prone to develop inﬂammation upon
induction of immune dysregulation. Hence, we used anti-
IL10R monoclonal antibody (aIL10R) to neutralize IL10
signaling to delineate their colitis susceptibility. Previously,
we showed that aIL10R treatment reproducibly induces a
uniform (100%) robust colitis in Tlr5KO mice.39,42 Lcn2KO
mice and their WT littermates were subjected to weekly
injections of aIL10R (intraperitoneally) for up to 4 weeks
and then euthanized 1 week after the last (fourth) injection.
aIL10R-treated Lcn2KO mice showed classic features of
chronic colitis such as body weight loss, shrunken ceca,
splenomegaly, and colomegaly (Figure 5A–D). Notably, 3 of
8 Lcn2KO mice developed rectal prolapse, a severe and
irreversible form of colitis, after the fourth injection.
Furthermore, enhanced immune cell inﬁltration was
observed in the colons of aIL10R-treated Lcn2KO mice
when compared with their aIL10R-treated WT littermates
(Figure 5E). However, colonic MPO was not increased in
aIL10R-treated Lcn2KO mice (data not shown), which
possibly is owing to reduced neutrophil inﬁltration in
Lcn2KO mice as observed in the DSS-induced acute colitis
(Supplementary Figure 6G and H). In addition, aIL10R-
treated mice showed increased systemic immunoreactivity
toward bacterial products LPS and ﬂagellin in both WT and
Lcn2KO mice (Figure 5F). Notably, Lcn2KO mice showed
more serum immunoreactivity to LPS than WT, suggesting
that increased dissemination of microbial products in
Lcn2KO mice might contribute further in augmenting sys-
temic inﬂammation and thus colitis.
Exacerbated Colitis in Lcn2KO Mice
Is Microbiota Dependent
Deﬁciency of Lcn2 leads to an increase in gut bacterial
load and favors the expansion of Bacteroidetes, which are
known to be associated with colitis in mice. Hence, we next
asked to what extent gut bacterial dysbiosis in Lcn2KO mice
contributes to their proneness to develop colitis on IL10R
neutralization. Lcn2KO mice were pretreated with broad-
spectrum antibiotics (ampicillin and neomycin in drinking
water) for up to 1 week and then subjected to 4 weekly
Figure 4. Lcn2-deﬁcient effector T cells are highly colitogenic in Rag1KO mice. Four-week-old female Rag1KO (n ¼ 5)
were given CD4þCD25- cells (0.5  106 cells/mouse intravenously, sorted via ﬂow cytometry) from Lcn2KO or their WT lit-
termates and disease pathogenesis was monitored. (A) Body weight, (B) gross colon, and (C) TNFa in ex vivo colon cultures.
(D) H&E-stained colons of Rag1KO control, WT recipients, and Lcn2KO recipients, and the (E) corresponding histologic score.
Results are expressed as means ± SEM. (A, C, and E) Unpaired t test and (C and E) the 1-way analysis of variance with the
Dunnett multiple comparison test were used. P < .05 was considered statistically signiﬁcant. *P < .05 and ***P < .001.
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biotics substantially ameliorated colitis in Lcn2KO mice
(Supplementary Figure 7). Antibiotic-treated Lcn2KO mice
showed less body weight loss, relatively smaller mesenteric
lymph nodes, normal colon length, and reduced spleen
weight, cecum and colon weight, and serum keratinocyte-
derived chemokine (Supplementary Figure 7A–G). In addi-
tion, immune cell inﬁltration and colonic inﬂammation also
were reduced substantially in antibiotic-treated Lcn2KO
mice (Supplementary Figure 7H–J).
To further investigate the extent to which Lcn2KO mice
harbor colitogenic microbiota, Lcn2KO or WT littermates
mice were co-housed (CoH) with the colitis-prone Il10KOmice, the latter were monitored for the development of
spontaneous colitis. Herein, Il10KO mice will be referred as
Lcn2KO-CoH and WT-CoH to correspond to the strains of co-
housed mice. Lcn2KO-CoH mice initially gained less body
weight compared with WT-CoH mice, but the body weight
loss became more apparent after 3 weeks (Figure 6A). After
6 weeks, approximately 50% of Lcn2KO-CoH mice devel-
oped rectal prolapse (data not shown). Notably, approxi-
mately 80% of Lcn2KO-CoH mice showed rectal prolapse by
8 weeks with concomitant splenomegaly and colomegaly
(Figure 6B–D). In comparison, no rectal prolapse was
observed in WT-CoH mice throughout the duration of this
study. Collectively, these results suggest that Lcn2KO mice
Figure 5. Lcn2KO mice develop severe IBD upon IL10R neutralization. Six-week-old male Lcn2KO mice and their WT
littermates (n ¼ 4-6) were treated with IL10R-neutralizing antibody (1.0 mg/mouse, intraperitoneally, weekly) for up to 4 weeks.
One week after the last (fourth) injection, mice were euthanized and analyzed for standard colitis parameters. (A) Body weight,
(B) gross pictures of colon and spleen (lower panel), (C) spleen weight, (D) colon weight, and (E) H&E-stained colon sections. (F)
Bar graphs represent immunoreactivity to LPS and ﬂagellin in the serum samples obtained from control and aIL10R-treated
WT and Lcn2KO mice. Results are expressed as means ± SEM. (A) Unpaired t test and (C, D, and F) 1-way analysis of variance
with the Tukey multiple comparison test were used. P < .05 was considered statistically signiﬁcant. *P < .05, **P < .01, and
***P < .001.






(21 days), male Lcn2KO,
WT, and Il10KO mice (n ¼
10) were co-housed and
monitored for body weight,
sticky stools, and rectal
prolapse as the end point.
(A) Line graph shows the
percentage change in the
body weight of Il10KO
mice CoH with WT or
Lcn2KO mice. (B) Mice
were observed continu-
ously for up to 8 weeks for
the development of rectal
prolapse. After 8 weeks the
mice were euthanized and
analyzed for colitic param-
eters. Bar graphs represent
the (C) spleen weight and
(D) colon weight. Results
are expressed as means ±
SEM. (A–C and E) An
unpaired t test was used.
P < .05 was considered
statistically signiﬁcant.
*P < .05 and ***P < .001.
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community in the gut, but a colitogenic microbiota that is
transmissible and can exacerbate spontaneous colitis in
susceptible hosts such as Il10KO mice.Discussion
During IBD, the host expresses a plethora of proin-
ﬂammatory (eg, TNFa) and anti-inﬂammatory (eg, IL10)molecules, accompanied by APPs, wherein the latter repre-
sent a presumed attempt to restore immunologic equilib-
rium. One such APP, Lcn2, which belongs to a family of small
secreted glycoproteins, confers several physiological func-
tions: controlling gut bacterial overgrowth and promoting
mucosal regeneration and tissue repair, which can modulate
gut health. By using bone marrow chimeric mice, we further
conﬁrmed that nonimmune cells, possibly IECs47 and he-
patocytes,57 contribute the majority of systemic Lcn2 during
July 2016 Microbiota-Dependent Colitis in Lcn2KO Mice 495the normal and inﬂamed states. To a lesser extent, the levels
of circulating Lcn2 also are contributed by immune cells,
particularly neutrophils that express and store rich amounts
of Lcn2 in their granules.13,58 Colocalization of Lcn2 with
immune cells in the inﬂamed colon suggests that immune
cells clearly contribute to increased intestinal Lcn2 upon
DSS-induced inﬂammation, although future studies will be
needed to determine the role of such Lcn2 in regulating gut
inﬂammation. We further showed that, in vivo, Lcn2
expression is regulated by gut microbiota and in a partial
MyD88-dependent fashion. Although the data presented
here point prominently to MyD88 signaling being required
for Lcn2 production in the inﬂamed colon, it should be
acknowledged that MyD88-dependent signaling may not
account solely for the release of Lcn2 in the colon during
colitis. However, there is a possibility that other signaling
pathways, which are not examined in the present study, also
may contribute to the induction of Lcn2 during IBD.
Intriguingly, the absence of Lcn2 led to the increase of
procolitogenic factors, which include increased colonic
bacterial adhesive proteins, gut bacterial burden, and
expansion of Bacteroidetes. Accordingly, both acute and
chronic colitis were exacerbated and more pronounced in
mice lacking Lcn2. Gut sterilization and co-housing experi-
ments further suggest that the exacerbated colitis in Lcn2KO
mice could be the result of their gut microbiota dysbiosis.
Collectively, our study suggests that Lcn2 could play a key
role in maintaining a healthy gut microbiota composition,
thus reducing the susceptibility to develop colitis.
Neutrophils play a critical role in maintaining intestinal
homeostasis as appropriate, and timely mucosal neutrophil
inﬁltration is needed for proper initiation, perpetuation, and
resolution of inﬂammation. Published reports have indi-
cated that Lcn2 facilitates neutrophil recruitment at the
inﬂammatory site by inducing IL8, a bona ﬁde chemotactic
agent.19,26,59 Moreover, Lcn2 itself is an indispensable factor
for neutrophil adhesion, migration, and function.26 Accord-
ingly, mice lacking Lcn2 show reduced neutrophil inﬁltra-
tion and colonic MPO activity in response to intestinal
inﬂammation. The impaired neutrophil inﬁltration in
Lcn2KO mice may compromise neutrophil-mediated defense
against bacterial overgrowth and also potentially impair the
recruitment of other immune cells that are necessary to
promote mucosal healing.56 However, excessive recruitment
of immune cells also could result in acute ﬂares of IBD.56 A
recent study showed that junctional adhesion molecule-like
protein, which is derived from neutrophils, inhibits wound
repair by reducing epithelial proliferation.60 Thus, during
intestinal inﬂammation, neutrophil functions can be viewed
as a double-edged sword that keeps gut bacteria in check
and helps in mucosal repair, whereas uncontrolled neutro-
phil inﬁltration may result in IBD ﬂares and worsen the IBD.
Lcn2 has been reported to mediate both anti-
inﬂammatory or proinﬂammatory functions depending on
the circumstances. In various acute and chronic inﬂamma-
tory disorders, the signiﬁcantly increased levels of Lcn2 are
shown to perform several key anti-inﬂammatory functions:
supporting the M2 macrophage phenotype switch28 that
promotes wound healing and ﬁbrosis,61 inducing theanti-inﬂammatory cytokine IL10 by macrophages,28 serving
as a survival factor22 (which favors ulcer healing), promoting
cell migration and wound repair,62 acting as an endogenous
inhibitor of inﬂammation,63 and controlling gut bacterial
overgrowth by preventing its iron uptake.23 Furthermore,
increased proinﬂammatory and procolitogenic responses
are observed in immune cells lacking Lcn2.18,64 Accordingly,
we also observed a heightened colitogenic capacity of Lcn2-
deﬁcient T cells (CD4þCD25-) upon their transfer into
recipient Rag1KO mice. Altogether, gut bacterial dysbiosis,
dysregulated immune cell response, and compromised
repair mechanisms during Lcn2 deﬁciency could increase the
likelihood of Lcn2KO mice to develop colitis.
However, on the ﬂip side, several studies also have re-
ported the proinﬂammatory aspect of Lcn2, as follows: (1) it
induces proinﬂammatory signaling in Alzheimer’s disease,65
(2) siderophore-bound Lcn2 induces the release of proin-
ﬂammatory IL8 and IL6 from epithelial cells,20,66 and (3) the
absence of Lcn2 protects against Salmonella enterica sero-
var Typhimurium-induced colitis in mice.67 Further mech-
anistic studies are warranted to elucidate the
proinﬂammatory vs the anti-inﬂammatory properties of
Lcn2 and explore whether Lcn2 could be exploited as a
therapeutic target for IBD.
The healthy human gut predominantly harbors Firmi-
cutes (w64%) and Bacteroidetes (w23%), the other 2 phyla
are Proteobacteria (w8%) and Actinobacteria (w3%).68 Gut
bacterial dysbiosis has been associated with IBD68–70 and, in
particular, the expansion of Proteobacteria is known to be
correlated positively with the severity of IBD in both mice
and human beings.69,71 Among its multifaceted functions,
Lcn2 is known to exert antimicrobial pressure on bacterial
growth by chelating bacterial siderophore and limiting
bacterial acquisition of iron. Recently, we showed that Lcn2
mediates an additional function to preserve MPO activity by
preventing its inactivation by prototypical bacterial side-
rophore enterobactin produced by the opportunistic path-
ogen Escherichia coli.27 The present study highlights that
aggravated colitis in mice lacking Lcn2 could be, at least in
part, microbiota-dependent. Accordingly, Lcn2-deﬁcient
mice showed increased gut microbiotal load and altered
microbial community, characterized by signiﬁcant expan-
sion of Bacteroidetes, and, to a lesser extent, Proteobacteria.
Increased microbiota reﬂect an increased pool of bacterial
products (eg, lipopolysaccharide and ﬂagellin) and/or toxic
metabolites (trimethylamine N-oxide and taurocholate) at
levels that continuously insult the gut and deteriorate the
mucosal barrier. Previously, we showed that Lcn2-deﬁcient
mice are highly susceptible to bacterial and LPS-induced
sepsis.18 In support of this notion, we observed exacer-
bated colitis in Lcn2KO mice, suggesting a salient role of gut
microbiota in IBD pathogenesis. The mitigated colitis
phenotype in microbiota-ablated Lcn2KO mice and the
increased incidence of rectal prolapse in Il10KO mice when
co-housed with Lcn2KO further support our hypothesis that
microbiota play a key role in IBD pathogenesis in Lcn2KO
mice. Intriguingly, the profound up-regulation of Lcn2
expression was observed in colonic tissue of patients with
active IBD.47 It is plausible that increased levels of human
496 Singh et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 4Lcn2 can help to suppress the overgrowth of E coli, known
to be associated with IBD ﬂares, and induce overall changes
in the bacterial community, which could mitigate the
symptoms of IBD. Therefore, it would be interesting to
examine whether enhanced Lcn2 could regulate the gut
microbiota during active ulcerative colitis or active Crohn’s
disease in human beings. Furthermore, we envision future
studies that evaluate which form (monomeric vs dimeric)
and source (immune vs nonimmune) of Lcn2 is important,
which would advance our current understanding on the role
of Lcn2 during IBD.
Lcn2 has emerged in recent years as a biomarker of
several acute and chronic inﬂammatory diseases including
IBD.8,13,72 Indeed, mucosal Lcn2 often is increased in
patients with IBD32 and in colitic mice.8 In the present
study, we show that Lcn2 is a microbiota-induced and
MyD88-dependent protein in the gut; deﬁciency of Lcn2
aggravates both acute and chronic colitis in mice. Microbiota
ablation diminished the colitis in Lcn2KO mice whereas an
increased incidence of rectal prolapse in Il10KO mice was
observed when co-housed with Lcn2KO mice, suggesting
that Lcn2KO mice carry a microbiota with colitogenic
property. Collectively, we showed that Lcn2 is not just a
biomarker of gut inﬂammation, but its up-regulation pro-
tects against IBD by controlling, in part, gut bacterial dys-
biosis and proper neutrophil inﬁltration. Thus, Lcn2, similar
to its human ortholog NGAL, a small protein with a simple
structure and high structural plasticity, may be a promising
therapeutic agent to treat human IBD.References
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Supplementary Figure 3. Human neutrophils are the richest source of Lcn2. Human neutrophils, obtained from 4 different
individuals, and HT29 cells were lysed and analyzed for Lcn2 using ELISA. (A) Bar graph represents Lcn2 levels in human
neutrophils and HT29 cells. Human neutrophils (2  106/well) were stimulated with indicated stimuli in Hank’s balanced salt
solution for 1 hour at 37C and Lcn2 was assayed in (B) cell lysate and (C) cell supernatant by immunoblotting with and without
b-mercaptoethanol (bME). Results are expressed as means ± SEM. *P < .05. (A) An unpaired t test was used. P < .05 was
considered statistically signiﬁcant. ***P < .001.
Supplementary Figure 2. Nonimmune cells are principal contributors of circulating Lcn2. To explore the relative
contribution of immune and nonimmune cells in maintaining the circulating Lcn2, serum Lcn2 was measured in normal and
LPS-stimulated bone marrow chimeric mice (n ¼ 4-5). Bar graphs represent serum Lcn2 in (A) normal, (B) DSS (1.8%)
treatment (after 7 days), and (C) LPS-treated bone marrow chimeric mice. Results are expressed as means ± SEM. (A–C) One-
way analysis of variance with the Dunnett multiple comparison test was used. P < .05 was considered statistically signiﬁcant.
*P < .05, **P < .01, and ***P < .001.
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Supplementary Figure 5. Misclassiﬁcation error rate and heat map representation of the 17 most signiﬁcantly altered
operational taxonomic units (OTUs) in Lcn2KOmice. (A) Misclassiﬁcation error rate showing that 17 OTUs were sufﬁcient to
discriminate microbiota successfully from each experimental group (WT and Lcn2KO, error rate ¼ 0). (B) Relative expression of
the 17 most signiﬁcantly altered OTUs in Lcn2KO mice compared with WT mice. Green, WT; red, Lcn2KO. (C) Heat map
representation of the 17 most signiﬁcantly altered OTUs in Lcn2KO mice compared with WT mice. Colors represent the relative
expression (white and red for under-represented and overrepresented, respectively). The 17 OTUs are listed on the right using
their assigned taxonomy, starting with the phylum, then class, order, family, and genus. The dendrogram on the upper part
represents sample clustering.
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Supplementary Figure 6. Aggravated DSS-induced acute colitis in mice lacking Lcn2.WT and Lcn2KO mice (n ¼ 5) were
given 1.8% DSS and after 7 days were monitored for (A) body weight (B) gross colons, (C) spleen weight, and (D) colonic MPO.
H&E-stained colons from (E) WTþDSS and (F) Lcn2KOþDSS mice. Ly-6G–stained colons from (G) WTþDSS and (H)
Lcn2KOþDSS mice. Green, Ly6G; blue, 40,6-diamidino-2-phenylindole. Results are expressed as means ± SEM. *P < .05. (A,
C, and D) One-way analysis of variance with the Tukey multiple comparison test was used. P < .05 was considered statistically
signiﬁcant. *P < .05, **P < .01, and ***P < .001.
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Supplementary Figure 7. Microbiota ablation diminished colitis in anti-IL10R–treated Lcn2KO mice. Age-matched male
Lcn2KO mice (n ¼ 4-6) were maintained on the broad-spectrum antibiotics ampicillin and neomycin in drinking water. After 3
days, mice received a-IL10R mAb (1.0 mg/mouse, intraperitoneally, weekly) for up to 4 weeks and then were analyzed for the
development of colitis. (A) Body weight, (B) mesenteric lymph node, (C) gross image of colon, (D) spleen weight, (E) cecum
weight, (F) colon weight, (G) serum keratinocyte-derived chemokine (KC), and (H–J) the H&E-stained sections colonic tissue.
Results are expressed as means ± SEM. *P < .05. (A) Unpaired t test and (D–G) 1-way analysis of variance with the Tukey
multiple comparison test were used. P < .05 was considered statistically signiﬁcant. *P < .05 and ***P < .001. Abx, antibiotics.
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